SECOND CHINESE COVID-19 VACCINE APPROVED FOR EMERGENCY USE BY WHO
A second Chinese vaccine has been given approval for emergency use by the World Health Organisation (WHO).
After it met international standards for safety and efficacy, Sinovac-CoronaVac, a two-dose vaccine, got the nod.It is already being used in several countries.
WHO said it prevents symptoms in 51 per cent of those vaccinated and has a 100 per cent efficacy on severe Covid-19 hospitalisation cases.
The Emergency Use Listing (EUL) comes one month after WHO approved the first Chinese vaccine, Sinopharm, also for emergency use.
According to WHO Director-General Tedros Ghebreyesus, he on Wednesday said the vaccine’s easy storage contributed to its approval and inclusion in the Covax facility, for which Sinovac/China National Pharmaceutical Group has produced 10 million doses from a projected annual target of three billion doses by year’s end.
“Easy storage of CoronaVac makes it suitable for low resource settings,” Ghebreyesus explained.
It is now crucial to get these life-saving tools to the people that need them quickly,” he added.
CoronaVac comes at a time when the country is facing a shortage of vaccines, owing to a surge in Covid cases in India, which was supplying the bulk of AstraZeneca vaccines.
It's the eighth vaccine to receive EUL by WHO.